Certificate of Analysis (COA)
View the laboratory certificate for this product
[ View COA ]
Noventra TirReta – 2.4ml/60mg Multi Dose Pen (240 Clicks)
R 2,470.00 R 2,290.00
Noventra TirReta is an advanced dual-pathway metabolic peptide blend combining Tirzepatide 30mg and R3t@trutide 30mg in a single formulation. Designed to support aggressive weight management protocols, this hybrid peptide system targets GLP-1, GIP, and glucagon receptors to enhance appetite control, metabolic efficiency, and fat utilization.
The formulation is commonly used to support extreme appetite suppression, improved blood glucose control, enhanced fat oxidation, and preservation of lean muscle during calorie restriction phases. TirReta is designed for individuals seeking advanced body recomposition and high-level metabolic support.
Delivered through a convenient 2.4ml Multi Dose Pen with 240 clicks, TirReta allows for structured weekly dosing with precise click-based administration. The peptide blend is formulated to provide consistent appetite regulation, metabolic support, and sustained fat-loss assistance throughout progressive protocols.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its effects on appetite regulation, glucose metabolism, and weight management support.
Retatrutide Research
Retatrutide is a triple agonist peptide studied for its ability to activate GLP-1, GIP, and glucagon receptors to support energy expenditure and advanced fat metabolism.
Combined Metabolic Support
Research into multi-pathway peptide therapies suggests that combining these receptor pathways may support enhanced appetite suppression, improved satiety, and greater metabolic flexibility.
Body Composition & Fat Loss
The hybrid combination is commonly explored for aggressive fat-loss protocols, body recomposition support, and metabolic enhancement while maintaining lean muscle mass.
Research into metabolic peptide therapies remains ongoing and individual responses may vary.